Possible amelioration of atherogenic diet induced dyslipidemia, hypothyroidism and hyperglycemia by the peel extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats.
Hitherto unknown efficacy of the peel extracts of Mangifera indica (MI), Cucumis melo (CM) and Citrullus vulgaris (CV) fruits in ameliorating the diet-induced alterations in dyslipidemia, thyroid dysfunction and diabetes mellitus have been investigated in rats. In one study, out of 4 different doses (50-300 mg/kg), 200 mg/kg of MI and 100 mg/kg for other two peel extracts could inhibit lipidperoxidation (LPO) maximally in liver. In the second experiment rats were maintained on pre-standardized atherogenic diet CCT (supplemented with 4% cholesterol, 1% cholic acid and 0.5% 2-thiouracil) to induce dyslipidemia, hypothyroidism and diabetes mellitus and the effects of the test peel extracts (200 mg/kg of MI and 100 mg/kg for CM and CV for 10 consecutive days) were studied by examining the changes in tissue LPO (in heart, liver and kidney), concentrations of serum lipids, thyroid hormones, insulin and glucose. Rats, treated simultaneously with either of the peel extracts reversed the CCT-diet induced increase in the levels of tissue LPO, serum lipids, glucose, creatinine kinase-MB and decrease in the levels of thyroid hormones and insulin indicating their potential to ameliorate the diet induced alterations in serum lipids, thyroid dysfunctions and hyperglycemia/diabetes mellitus. A phytochemical analysis indicated the presence of a high amount of polyphenols and ascorbic acid in the test peel extracts suggesting that the beneficial effects could be the result of the rich content of polyphenols and ascorbic acid in the studied peels.
Parmar
Hamendra Singh
HS
Endocrine Research Unit, Devi Ahilya University, Indore, MP, India. hamendrasingh999@yahoo.co.in
Kar
Anand
A
D000818:Animals; D001205:Ascorbic Acid / Q000032:analysis; D050197:Atherosclerosis / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D029773:Citrullus / Q000737:chemistry*; D052279:Creatine Kinase, MB Form / Q000097:blood; D028463:Cucumis melo / Q000737:chemistry*; D003920:Diabetes Mellitus / Q000188:drug therapy; D004036:Diet, Atherogenic; D050171:Dyslipidemias / Q000188:drug therapy*; D005419:Flavonoids / Q000032:analysis; D005638:Fruit / Q000737:chemistry; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007037:Hypothyroidism / Q000188:drug therapy*; D015227:Lipid Peroxidation / Q000187:drug effects; D008055:Lipids / Q000097:blood; D031022:Mangifera / Q000737:chemistry*; D010636:Phenols / Q000032:analysis; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D059808:Polyphenols; D051381:Rats; D017208:Rats, Wistar; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D001786:Blood Glucose; D005419:Flavonoids; D007004:Hypoglycemic Agents; D008055:Lipids; D010636:Phenols; D010936:Plant Extracts; D059808:Polyphenols; D014284:Triiodothyronine; D052279:Creatine Kinase, MB Form; D001205:Ascorbic Acid; D013974:Thyroxine